| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/18/2014 | US8653102 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators |
| 02/18/2014 | US8653101 Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators |
| 02/18/2014 | US8653100 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 02/18/2014 | US8653099 Cold menthol receptor antagonists |
| 02/18/2014 | US8653098 Pyrazolopyridine PI3K inhibitor compounds and methods of use |
| 02/18/2014 | US8653097 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (P13-kinases) inhibitor |
| 02/18/2014 | US8653096 Chemokine receptor antagonists and methods of use thereof |
| 02/18/2014 | US8653095 Small molecules with antimalarial activity |
| 02/18/2014 | US8653094 Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use |
| 02/18/2014 | US8653093 Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 02/18/2014 | US8653092 Tetrahydro-pyrido-pyrimidine derivatives |
| 02/18/2014 | US8653091 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 02/18/2014 | US8653090 Compositions and methods for treatment of the side-effects associated with administration of cancer chemotherapeutic agents |
| 02/18/2014 | US8653089 Heterocyclic compounds and methods of use |
| 02/18/2014 | US8653088 Compositions useful as inhibitors of protein kinases |
| 02/18/2014 | US8653087 Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors |
| 02/18/2014 | US8653086 Naphthamides as anticancer agents |
| 02/18/2014 | US8653085 Diketopiperazine salts for drug delivery and related methods |
| 02/18/2014 | US8653084 Hydrobenzamide derivatives as inhibitors of Hsp90 |
| 02/18/2014 | US8653083 Hedgehog pathway antagonists to treat disease |
| 02/18/2014 | US8653082 6-phenyl-2-[((piperidin-4-ylmethyl)-piperazin-1YL) or piperazin 1-ylmethyl)-piperidin-1-yl)]-imidazo[2,1-B][1,3,4]thiadiazole derivatives and their use |
| 02/18/2014 | US8653081 Certain chemical entities, compositions, and methods |
| 02/18/2014 | US8653080 Methods for screening and compounds that protect against amyloid diseases |
| 02/18/2014 | US8653079 Pyrazolo [4,3-C] cinnolin-3-one M1 receptor positive allosteric modulators |
| 02/18/2014 | US8653078 Herbicidal pyrido[2,3-b]pyrazines |
| 02/18/2014 | US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 02/18/2014 | US8653076 Oxo-substituted imidazo[1,2B]pyridazines, their preparation and use as pharmaceuticals |
| 02/18/2014 | US8653075 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 02/18/2014 | US8653074 Substituted sodium 1H-pyrazol-5-olate |
| 02/18/2014 | US8653073 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/18/2014 | US8653072 Estrogen receptor ligands |
| 02/18/2014 | US8653071 α4β2 neuronal nicotinic acetylcholine receptor ligands |
| 02/18/2014 | US8653070 Hepatitis C virus inhibitors |
| 02/18/2014 | US8653069 Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia |
| 02/18/2014 | US8653068 Filamin A binding anti-inflammatory and analgesic |
| 02/18/2014 | US8653067 Pharmaceutical composition for treating Alzheimer's disease |
| 02/18/2014 | US8653066 Pharmaceutical compositions |
| 02/18/2014 | US8653065 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 02/18/2014 | US8653064 Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoate |
| 02/18/2014 | US8653063 N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity |
| 02/18/2014 | US8653062 Compounds as receptor modulators with therapeutic utility |
| 02/18/2014 | US8653061 Acetylcysteine composition and uses thereof |
| 02/18/2014 | US8653060 Formulations of 6-mercaptopurine |
| 02/18/2014 | US8653059 Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 02/18/2014 | US8653058 Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
| 02/18/2014 | US8653057 Prophylactic perioperative testosterone supplementation for protection of and recovery of function |
| 02/18/2014 | US8653056 Method of preparation of a soluble formulation of water-insoluble pentacyclic and tetracyclic terpenoids, a soluble formulation of a pentacyclic or tetracyclic terpenoid and a pharmaceutical composition containing this soluble formulation |
| 02/18/2014 | US8653055 Corticosteroid having low systemic absorption |
| 02/18/2014 | US8653054 2-(N-substituted piperazinyl) steroid derivatives |
| 02/18/2014 | US8653053 Topical skin care composition |
| 02/18/2014 | US8653052 Drug combination and its use in the treatment of muscle loss |
| 02/18/2014 | US8653051 Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction |
| 02/18/2014 | US8653050 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 02/18/2014 | US8653049 Normuramyl glycopeptide compounds |
| 02/18/2014 | US8653048 Prodrugs based on gemcitabine structure and synthetic methods and applications thereof |
| 02/18/2014 | US8653043 Enhanced neoglycosides through neoglycosylation and methods of use thereof |
| 02/18/2014 | US8653042 Antibacterial aminoglycoside analogs |
| 02/18/2014 | US8653041 Antibacterial aminoglycoside analogs |
| 02/18/2014 | US8653033 Method for administering omega-conopeptide |
| 02/18/2014 | US8653026 Treatment of type 2 diabetes with FTY720 |
| 02/18/2014 | US8653021 Targeting PAX2 for the treatment of breast cancer |
| 02/18/2014 | US8653003 Pyrazol-4-yl carboxamide derivatives as microbiocides |
| 02/18/2014 | US8653002 Aqueous suspension concentrate formulations containing saflufenacil |
| 02/18/2014 | US8653000 Imine substituted 2,4-diaryl-pyrroline derivatives as pesticides |
| 02/18/2014 | US8652998 Branched copolymer/anthranilic diamide compositions for propagule coating |
| 02/18/2014 | US8652537 Herbal drug composition for cartilage protection |
| 02/18/2014 | US8652536 Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof |
| 02/18/2014 | US8652534 Compositions and methods for treatment of mammalian skin |
| 02/18/2014 | US8652532 Food composition comprising glucosamine |
| 02/18/2014 | US8652528 Drug loaded polymeric nanoparticles and methods of making and using same |
| 02/18/2014 | US8652526 Drug carrier and drug carrier kit for inhibiting fibrosis |
| 02/18/2014 | US8652525 NSAID delivery from polyarylates |
| 02/18/2014 | US8652524 Organ regeneration device |
| 02/18/2014 | US8652521 Coated solid preparation |
| 02/18/2014 | US8652519 Dissolution properties of drug products containing olmesartan medoxomil |
| 02/18/2014 | US8652517 Coating of tablet cores |
| 02/18/2014 | US8652513 Film-forming starchy composition |
| 02/18/2014 | US8652499 Medical antimicrobial composition and medical device comprising the same |
| 02/18/2014 | US8652496 Biocides and apparatus |
| 02/18/2014 | US8652491 Transdermal compositions for anticholinergic agents |
| 02/18/2014 | US8652480 Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides |
| 02/18/2014 | US8652464 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
| 02/18/2014 | US8652456 Aqueous preparations comprising at least one water-soluble or water-dispersible copolymer with cationgenic groups |
| 02/18/2014 | US8652444 Oral compositions containing biphenol antibacterial compounds |
| 02/18/2014 | CA2764401C Ectoparasiticidal formulations comprising spinetoram and methods of use thereof |
| 02/18/2014 | CA2755954C Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists |
| 02/18/2014 | CA2744857C Cyclobutyl purine derivative, angiogenesis promoting agent, lumen formation promoting agent, neurocyte growth promoting agent, and drug |
| 02/18/2014 | CA2743264C Tetrasubstituted pyridazines hedgehog pathway antagonists |
| 02/18/2014 | CA2737102C Benzimidazole anthelmintic compositions |
| 02/18/2014 | CA2736965C Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/18/2014 | CA2726987C Stat3 inhibitors |
| 02/18/2014 | CA2724023C Salicylate conjugates useful for treating metabolic disorders |
| 02/18/2014 | CA2716706C Compounds and compositions as tlr activity modulators |
| 02/18/2014 | CA2711840C Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 02/18/2014 | CA2701594C Heterocycle phenyl amide t-type calcium channel antagonists |
| 02/18/2014 | CA2698172C Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 02/18/2014 | CA2677430C Compositions comprising dietary fat complexer and methods for their use |
| 02/18/2014 | CA2659689C Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 02/18/2014 | CA2654644C Novel process and intermediates |
| 02/18/2014 | CA2636638C A method of treating an acute vascular disorder |